AVI BioPharma, Inc. Completes Registered Direct Offering, Raises $20.3 Million

December 20, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (NASDAQ: AVII) has successfully completed its previously announced registered direct offering consistent with the terms and conditions announced in AVI BioPharma’s December 12, 2007 press release.

Twitter
LinkedIn
Facebook
Email
Print

Sarepta Therapeutics, Inc.